Skip to main content
Article thumbnail
Location of Repository

ATR-FTIR spectroscopy detects alterations induced by organotin(IV) carboxylates in MCF-7 cells at sub-cytotoxic/-genotoxic concentrations

By Muhammad S Ahmad, Bushra Mirza, Mukhtiar Hussain, Muhammad Hanif, Saqib Ali, Michael J Walsh and Francis L Martin

Abstract

The environmental impact of metal complexes such as organotin(IV) compounds is of increasing concern. Genotoxic effects of organotin(IV) compounds (0.01 μg/ml, 0.1 μg/ml or 1.0 μg/ml) were measured using the alkaline single-cell gel electrophoresis (comet) assay to measure DNA single-strand breaks (SSBs) and the cytokinesis-block micronucleus (CBMN) assay to determine micronucleus formation. Biochemical-cell signatures were also ascertained using attenuated total reflection Fourier-transform infrared (ATR-FTIR) spectroscopy. In the comet assay, organotin(IV) carboxylates induced significantly-elevated levels of DNA SSBs. Elevated micronucleus-forming activities were also observed. Following interrogation using ATR-FTIR spectroscopy, infrared spectra in the biomolecular range (900 cm-1 – 1800 cm-1) derived from organotin-treated MCF-7 cells exhibited clear alterations in their biochemical-cell fingerprint compared to control-cell populations following exposures as low as 0.0001 μg/ml. Mono-, di- or tri-organotin(IV) carboxylates (0.1 μg/ml, 1.0 μg/ml or 10.0 μg/ml) were markedly cytotoxic as determined by the clonogenic assay following treatment of MCF-7 cells with ≥ 1.0 μg/ml. Our results demonstrate that ATR-FTIR spectroscopy can be applied to detect molecular alterations induced by organotin(IV) compounds at sub-cytotoxic and sub-genotoxic concentrations. This biophysical approach points to a novel means of assessing risk associated with environmental contaminants

Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2666631
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (1979). Anal Chem
    2. (2004). Annu Rep Prog Chem Sect A
    3. (2005). Appl Organomet Chem
    4. (1999). Ballarin L: Appl Organomet Chem
    5. (2002). Bioorg Med Chem Lett
    6. (1999). DH: Biochem Biophys Res Commun
    7. (1997). DH: Carcinogenesis
    8. (2000). DH: Mutat Res
    9. (2000). E: Toxicol Appl Pharmacol
    10. (2004). FL: Carcinogenesis
    11. (2004). FL: Environ Sci Technol
    12. (2006). FL: Mutagenesis
    13. (2006). Heteroatom Chem
    14. (2002). Huang JK: Life Sci
    15. (2005). Inorg Biochem
    16. (1999). Mutat Res
    17. (2003). Nok AJ: Jpn Parasitolog Res
    18. (1998). Omachi AA: Metal-Based Drugs
    19. (2006). Organomet Chem
    20. (2004). Polymeric Platinum-containing Drugs in the Treatment of Cancer.
    21. (1992). Salzer A: Organometallics, a concise introduction. 2nd edition.
    22. (2006). Sci Total Environ
    23. (2005). Supuran CT:
    24. (2006). Supuran CT: J Enzyme Inhibit Med Chem
    25. (1993). TC: Biochem Biophys Res Commun
    26. (1994). Tiekink ERT: Trends Organomet Chem
    27. (1997). Toxicol Appl Pharmacol
    28. (2008). TS: Appl Organomet Chem
    29. (1999). Venitt S: Mutat Res
    30. (2000). WR: Biopolymers

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.